NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC): Nasdaq/NYSE listing notice — NeuroOne receives Nasdaq delisting determination for bid price non-compliance; intends to appeal

NEUROONE MEDICAL TECHNOLOGIES Corp

Received delisting determination from Nasdaq on Jan 8, 2025 for continued non-compliance with $1.00 minimum bid price rule.
180-day compliance period ended Jan 7, 2025; company failed to regain compliance.
Company will request a hearing before Nasdaq Hearings Panel to appeal; hearing stays delisting action pending outcome.
Common stock (NMTC) remains listed and tradable at least until final hearing conclusion.
No assurance of regaining compliance or continued listing on Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

NEUROONE MEDICAL TECHNOLOGIES Corp received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

January 8, 2025, the Company received a letter from the Staff indicating the Company’s continued non-compliance with the Minimum Bid Price Requirement. The letter further informed the Company that the Company’s common stock would be delisted from The Nasdaq Capital Market unless the Company appeals the Staff’s delisting determination by requesting a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company’s request for a hearing will stay any further delisting action by the Staff pending the ultimate outcome of the hearing. The Company’s common stock will remain listed and eligible

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

NEUROONE MEDICAL TECHNOLOGIES Corp received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

January 8, 2025, the Company received a letter from the Staff indicating the Company’s continued non-compliance with the Minimum Bid Price Requirement. The letter further informed the Company that the Company’s common st

View on SEC.gov

Browse all listing & compliance notices →

NEUROONE MEDICAL TECHNOLOGIES Corp filing history →

Source: SEC EDGAR

accession 0001213900-25-002728

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.